GUANGZHOU, China, March 2, 2021 / PRNewswire / – Merck, a leading science and technology company, today signed a memorandum of understanding to begin a strategic collaboration with Guangzhou Pharmaceutical Holdings Limited (GPHL), the leading pharmaceutical company from China. The collaboration aims to explore areas such as new business model innovation, pipeline innovation and market expansion, taking advantage of unique development opportunities for the biopharmaceutical industry in the Guangdong Great Bay area. -Hong Kong-Macao.
Photo: Participants in the Merck and GPHL signing ceremony. (From from left to right: Stefan Oschmann, Chairman of the Management Board and CEO of Merck; Jeff Mo, Business Channel Development Manager for Merck’s Healthcare business in China; Yannick Debes, director of …
News Highlights Business
- Headline: Merck and GPHL collaborate on innovation and business development in the Grande Baie region
- Check all news and articles from the Business news updates.